Centocor, Eli Lilly sales and marketing update

Lilly said its third quarter sales of CNTO's ReoPro were $6.5 million, of which $1 million were to wholesalers, and $300,000 was sold internationally. CNTO said those numbers may not be indicative of the Malvern, Penn., company's sales of the antiplatelet antibody. "The $6.5 million represents Lilly's sales to hospitals; it doesn't represent our sales to Lilly," a CNTO spokesperson said. CNTO will announce its third quarter results following the market close on Nov. 1. ...